Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Preferred Stock Liabilities (2018 - 2019)

NovaBridge Biosciences (NBP) reported Preferred Stock Liabilities of $440.4 million for Q4 2019, up 4.45% year-over-year from $421.6 million in Q4 2018, and up 4.45% on a QoQ basis from $421.6 million in Q4 2018.

NovaBridge Biosciences (NBP) has 2 years of Preferred Stock Liabilities data on file, last reported at $440.4 million in Q4 2019.

  • Quarterly Preferred Stock Liabilities rose 4.45% year-over-year to $440.4 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $440.4 million (up 4.45% YoY) and the FY2019 annual result came in at $26.2 million, down 93.8% from the prior year.
  • Preferred Stock Liabilities advanced to $440.4 million in Q4 2019 per NBP's latest filing, from $421.6 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $440.4 million in Q4 2019 and bottomed at $421.6 million in Q4 2018.

Historic Data

Download Data 🔒
DateValue
Dec 31, 2019 440.42 Mn
Dec 31, 2018 421.65 Mn